Lisa M Neff

Affiliations

Eli Lilly and Company, Indianapolis, Indiana, USA.

Publications (2)

Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT-1 trial.

Diabetes, obesity & metabolism

Avec: Emily R Hankosky , Hui Wang , Lisa M Neff , Hong Kan , Fangyu Wang , Nadia N Ahmad , Adam Stefanski , W Timothy Garvey

Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis.

Diabetes, obesity & metabolism

Avec: Emily R Hankosky , Hui Wang , Lisa M Neff , Hong Kan , Fangyu Wang , Nadia N Ahmad , Ryan Griffin , Adam Stefanski , W Timothy Garvey

Réseau de co-auteurs

Emily R Hankosky 2 collaborations

Hui Wang 2 collaborations

Hong Kan 2 collaborations

Fangyu Wang 2 collaborations

Nadia N Ahmad 2 collaborations

Adam Stefanski 2 collaborations

W Timothy Garvey 2 collaborations

Ryan Griffin 1 collaboration